Search
for
Sort by
Research 241–270 of 1000+
- AN UPDATED OVERVIEW OF POLYCYSTIC OVARY SYNDROME
- Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- ADVANCEMENTS IN TREATMENT STRATEGIES FOR ANDROGENETIC ALOPECIA: NOVEL THERAPIES AND FUTURE PERSPECTIVES
- Use of Myoinositol in PCOS
- Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment
- Updates in Treatment for Androgenetic Alopecia
- Molecular Aspects of Polycystic Ovarian Syndrome in Female Population in Karnataka at the Southwestern Region of India
- Oral Presentations
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- The Hair-An Syndrome: A Report of a Misdiagnosed Case with Unfortunate Outcome
- Faculty Opinions recommendation of Promising therapies for treating and/or preventing androgenic alopecia.
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
- Androgenetic alopecia and risk of coronary artery disease
- Floral attractants in the black orchid Brasiliorchis schunkeana (Orchidaceae, Maxillariinae): clues for presumed sapromyophily and potential antimicrobial activity
- Evidence of Increased 3‐Alpha‐Androstanediol Glucuronide in Female Pattern Alopecia: A Cross‐Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens
- The Serum Evaluation of Sex Hormones Including DHEAs, DHT, Testosterone in Oral Lichen Planus Patients
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Dodatek A: Model matematyczny AL/RC/ASE. Functional Androgen Axis (FOA) - wersja operacyjna v1.2
- Cardiometabolic profile of young women with hypoprolactinemia
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Guidelines based management of androgenetic alopecia
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- Adrenal and Gonadal Activity, Androgen Concentrations, and Adult Height Outcomes in Boys With Silver-Russell Syndrome